Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Dermatology Case Question: May

Alisa Femia, MD, and Joseph F. Merola, MD  |  Issue: May 2013  |  May 1, 2013

Dermatology Case
Figure 1: Cutaneous eruption located on the sole of the foot.

The Case

A 60-year-old man with a history of seropositive rheumatoid arthritis (RA) presents with a new-onset, somewhat painful, cutaneous eruption located on the palms and soles (see Figure 1). He feels well otherwise and has no other systemic complaints. On exam, he is afebrile and his joint exam is unchanged from his last visit two months earlier. Medications include methotrexate 15 mg orally once weekly (for two years) and adalimumab 40 mg subcutaneous injection every two weeks (beginning two months ago).

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

What is your diagnosis?

  1. Pustular ‘Id’ reaction
  2. Keratoderma blennorrhagicum
  3. Tumor necrosis factor–α-induced palmo plantar pustular psoriasis
  4. Dyshidrotic eczema
  5. Impetigo

 


Dr. Femia is a fellow in the dermatology–rheumatology fellowship at Brigham and Women’s Hospital in Boston. She is a diplomat of the American Board of Dermatology.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Merola is an instructor in the department of dermatology at Harvard Medical School and a fellow in the rheumatology division at Brigham and Women’s Hospital, both in Boston. He is the assistant program director for the combined medicine–dermatology training program and a diplomat of the American Board of Dermatology and the American Board of Internal Medicine.

Share: 

Filed under:Conditions

Related Articles

    Case Report: A Bullous Eruption

    June 14, 2022

    Eosinophilic granulomatosis with polyangiitis (EGPA) is an anti-neutrophil cytoplasmic antibody-associated vasculitis typically characterized by asthma, peripheral eosinophilia and medium- to small-vessel necrotizing vasculitis. Cutaneous manifes­tations in EGPA are diverse. Palpable purpura is the most common presentation, but urticaria, erythematous macules and papules, livedo reticularis, digital necrosis and cutaneous nodules have also been described.1 Non-hemorrhagic bullae…

    Dermatology Case Answer C: May

    May 14, 2013

    C) Tumor necrosis factor (TNF)–α-induced palmoplantar pustular psoriasis

    Dermatology Case Answer A: May

    May 14, 2013

    A) Pustular ‘Id’ reaction

    Dermatologist, Rheumatologist Discuss Refractory Cutaneous Lupus Case

    September 5, 2022

    As a dermatologist/internist with a career-long subspecialty interest in the cutaneous manifestations of the rheumatic diseases, I found the case of refractory acute cutaneous lupus by Samantha C. Shapiro, MD, in the June 2022 issue of The Rheumatologist intriguing in several ways, and I felt my perspectives on this case might provide additional educational value…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences